Last reviewed · How we verify

NCT03951441

Construct Validity and Reliability SCALE

Status unknown Last updated 15 May 2019
What this trial tests

trial in Cerebral Palsy in 52 participants. Status unknown.

Timeline
9 October 2017
Primary endpoint
20 June 2019
22 July 2019

Quick facts

Lead sponsorHacettepe University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment52
Start date9 October 2017
Primary completion20 June 2019
Estimated completion22 July 2019
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 4 to 18, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to determine construct validity, discriminant validity and intra- and interrater reliability of the Selective Control Assessment of the Lower Extremity ( SCALE).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03951441.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing